# Schall Law Firm

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/schall-law-firm
Canonical HTML page: https://getbiobrief.com/entity/schall-law-firm

## Timeline

- **2026-03-12**: Litigation Commencement — Schall Law Firm announces class action lawsuits against both SLNO and RARE.
- **2026-02-26**: Soleno Executive Turnover — Official filing confirms the departure of several directors and officers.
- **2026-02-25**: Soleno Financial Results — Soleno files annual results and operational updates.
- **2026-02-12**: Ultragenyx Restructuring Disclosure — Company files SEC report detailing costs for exit or disposal activities.

## Recent coverage (1 stories)

### Schall Law Firm Targets Soleno and Ultragenyx in Securities Fraud Litigation
2026-03-12 10:06:11 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

The Schall Law Firm has initiated securities fraud class action lawsuits against biotech players Soleno Therapeutics and Ultragenyx Pharmaceutical. The legal actions follow a series of corporate disclosures in early 2026, inviting impacted investors to lead the litigation efforts.
Full story: https://getbiobrief.com/story/soleno-ultragenyx-securities-fraud-lawsuits-schall

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.